These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35264539)

  • 1. [Examination of the effect of immunosuppressive therapy on acquired hemophilia A in elderly patients with bloodstream infections].
    Aota Y; Amano K; Kurata T; Sutoh A; Moriyama M; Namioka N; Okabe M; Shinozawa K; Yokoyama T; Gotoh A
    Nihon Ronen Igakkai Zasshi; 2022; 59(1):90-95. PubMed ID: 35264539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel treatment strategies for acquired hemophilia A].
    Higasa S
    Rinsho Ketsueki; 2024; 65(6):560-566. PubMed ID: 38960657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acquired hemophilia A with reappearance of inhibitor 10 years after the completion of immunosuppressive therapy].
    Oshida K; Ito T; Shirayama R; Kusuhara K; Sato T; Sakai M
    Rinsho Ketsueki; 2021; 62(3):186-189. PubMed ID: 33828012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse of Acquired Hemophilia A after COVID-19 Infection.
    Marumo A; Sugihara H; Omori I; Morishita E
    J Nippon Med Sch; 2024 Jan; 90(6):474-479. PubMed ID: 36823120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acquired hemophilia A].
    Tokugawa T
    Rinsho Ketsueki; 2020; 61(7):785-790. PubMed ID: 32759566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overshoot of FVIII activity in patients with acquired hemophilia A who achieve complete remission.
    Ogawa Y; Yanagisawa K; Naito C; Uchiumi H; Ishizaki T; Shimizu H; Gohda F; Ieko M; Ichinose A; Handa H
    Int J Hematol; 2020 Apr; 111(4):544-549. PubMed ID: 31939075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful immunosuppressive therapy in female hemophilia A developing inhibitor after perioperative administration of factor VIII products].
    Yamaguchi M; Takaki Y; Yamasaki Y; Oya S; Nakamura T; Morishige S; Aoyama K; Mouri F; Takase R; Matsuo Y; Osaki K; Nagafuji K; Okamura T
    Rinsho Ketsueki; 2024; 65(2):90-94. PubMed ID: 38448004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of acquired hemophilia A during maintenance therapy for immune thrombocytopenia].
    Ogawa Y; Yanagisawa K; Ishizaki T; Naito C; Mihara M; Handa H; Shizuka R; Inoue M; Naito S; Ieko M; Ichinose A; Nojima Y
    Rinsho Ketsueki; 2016 Apr; 57(4):456-60. PubMed ID: 27169450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two elderly patients with difficult-to-treat acquired hemophilia A].
    Saito M; Morioka M
    Nihon Ronen Igakkai Zasshi; 2016; 53(4):424-430. PubMed ID: 27885231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Severe Acquired Haemophilia A with Immunosuppressive Agent: A Case Report of One Patient.
    Škunca Ž; Peraica AP
    Coll Antropol; 2016 Jun; 40(2):139-43. PubMed ID: 29139630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression Therapy in Acquired Hemophilia A: Pursuing an Optimal Regimen.
    Teixeira Passos D; Abrantes AM; Santos L; Cardoso A; Pais de Lacerda A
    Cureus; 2021 Dec; 13(12):e20467. PubMed ID: 35047291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coagulative complete remission following early gastric cancer resection in a patient with steroid-resistant acquired hemophilia A and nephrotic syndrome].
    Matsumoto A; Ogawa Y; Osaki T; Souri M; Takei H; Ishikawa T; Kobayashi N; Miyazawa Y; Ishizaki T; Inoue M; Ichinose A; Handa H
    Rinsho Ketsueki; 2023; 64(3):203-208. PubMed ID: 37019674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan.
    Ogawa Y; Yanagisawa K; Uchiumi H; Ishizaki T; Mitsui T; Gouda F; Ieko M; Ichinose A; Nojima Y; Handa H
    Int J Hematol; 2017 Jul; 106(1):82-89. PubMed ID: 28299631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired Hemophilia A following Pfizer-BioNTech SARS CoV-2 mRNA vaccine, successfully treated with prednisolone and rituximab.
    Murali A; Wong P; Gilbar PJ; Mangos HM
    J Oncol Pharm Pract; 2022 Sep; 28(6):1450-1453. PubMed ID: 35088622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor eradication and bleeding management of acquired hemophilia A: a single center experience in China.
    Ye N; Liu Z; Xu G; Wang X; Wu F; Xu X; Wu W
    Hematology; 2019 Dec; 24(1):631-636. PubMed ID: 31514689
    [No Abstract]   [Full Text] [Related]  

  • 16. Emicizumab for the treatment of acquired hemophilia A.
    Knoebl P; Thaler J; Jilma P; Quehenberger P; Gleixner K; Sperr WR
    Blood; 2021 Jan; 137(3):410-419. PubMed ID: 32766881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tipping point: The critical role of therapeutic apheresis in a case of refractory acquired hemophilia.
    Losos M; Scrape S; Joshi S; Shmookler A; Chen J
    J Clin Apher; 2017 Dec; 32(6):564-566. PubMed ID: 27646211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L; Pitlik E
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The factor VIII:C/VWF:Ag ratio as a useful tool to predict relapse in patients with acquired haemophilia A: A retrospective cohort study.
    Trossaert M; Graveleau J; Thiercelin-Legrand MF; Sigaud M; Guerrero F; Neel A; Fouassier M; Sailler L; Chauveau D; Ternisien C; Huart A; Gillet B; Hamidou M; Bene MC; Voisin S
    Haemophilia; 2019 May; 25(3):527-534. PubMed ID: 31050100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.